The forecast for liver malignant neoplasms mortality in Brazil indicates a gradual increase from 6.3 in 2024 to 6.8 per hundred thousand men by 2028. The year-on-year increments are modest: 1.6% from 2024 to 2025, 1.56% from 2025 to 2026, 3.08% from 2026 to 2027, and 1.49% from 2027 to 2028. This translates to a compound annual growth rate (CAGR) of about 1.89% from 2024 through 2028.
Future trends to watch for include the impact of public health interventions, potential advancements in medical treatments, and broader socioeconomic factors, all of which could influence liver cancer mortality rates in Brazil. Tracking these elements is crucial for understanding and addressing the underlying causes of the trends.
